OOIR: Observatory of International Research

Papers

(The H4-Index of Translational Oncology is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Comment on: AI-supported modified risk staging for multiple myeloma cancer useful in real-world scenario	1695
NCI's publication affiliation conundrum: Reframing innovation to incentivize an equitable path for advocate representation	126
Clinical characteristics and treatment efficacy of immune checkpoint inhibitors (ICIs) in patients with ICIs-induced Adrenal insufficiency	115
68Ga-PSMA11 PET/CT for biochemically recurrent prostate cancer: Influence of dual-time and PMT- vs SiPM-based detectors	90
ERβ-regulated circATP2B1/miR-204–3p/TWIST1 positive feedback loop facilitates epithelial to mesenchymal transition in clear cell renal cell carcinoma	78
Hypericin mediated photodynamic therapy induces ferroptosis via inhibiting the AKT/mTORC1/GPX4 axis in cholangiocarcinoma	77
Identification of IMPA2 as the hub gene associated with colorectal cancer and liver metastasis by integrated bioinformatics analysis	75
OLFM4 depletion sensitizes gallbladder cancer cells to cisplatin through the ARL6IP1/caspase-3 axis	75
FUBP1 in human cancer: Characteristics, functions, and potential applications	67
Radiation from frequent whole-body CT scans induces systemic immunosuppression and immune activation of tumor tissue	62
XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant	60
Tumor treating fields: An emerging treatment modality for thoracic and abdominal cavity cancers	59
Connexin43 is associated with the progression of clear cell renal carcinoma and is regulated by tangeretin to sygergize with tyrosine kinase inhibitors	59
Single-treatment tumor ablation with photodynamic liposomal irinotecan sucrosulfate	58
ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma	53
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer	51
Pan-cancer analysis of super-enhancer-induced LINC00862 and validation as a SIRT1-promoting factor in cervical cancer and gastric cancer	49
A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma	49
A novel telomerase-derived peptide GV1001-mediated inhibition of angiogenesis: Regulation of VEGF/VEGFR-2 signaling pathways	48
Identification of metastasis-associated exoDEPs in colorectal cancer using label-free proteomics	48
Anti-PD-1/PD-L1 therapy for colorectal cancer: Clinical implications and future considerations	46
Prediction of chemotherapy response in breast cancer patients at pre-treatment using second derivative texture of CT images and machine learning	46
Commentary: Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma	45
Predictive value of peripheral blood leukocytes-based methylation of Long non-coding RNA MALAT1 and H19 in the chemotherapy effect and prognosis of gastric cancer	43
The double face of cold in cancer	42

Integrated multi-omics demonstrates enhanced antitumor efficacy of donafenib combined with FADS2 inhibition in hepatocellular carcinoma	41
Association of PIK3CA mutation with outcomes in HER2-positive breast cancer treated with anti-HER2 therapy: A meta-analysis and bioinformatic analysis of TCGA‑BRCA data	41
Investigating the molecular mechanisms and clinical potential of APO+ endothelial cells associated with PANoptosis in the tumor microenvironment of hepatocellular carcinoma using single-cell sequencin	41
Loss of p53 epigenetically modulates epithelial to mesenchymal transition in colorectal cancer	40
Corrigendum to “Genomic profiles and their relationships with clinical characteristics and immune features in cervical cancer” [Translational Oncology 44 (2024) 1–10/101923]	38
GSDME has prognostic and immunotherapeutic significance in residual hepatocellular carcinoma after insufficient radiofrequency ablation	37
CD44 occurring alternative splicing promotes cisplatin resistance and evokes tumor immune response in oral squamous cell carcinoma cells	37
LncRNA DGUOK-AS1 facilitates non-small cell lung cancer growth and metastasis through increasing TRPM7 stability via m6A modification	36
The Potential Role of C4 MYH11+ Fibroblasts and the MDK-SDC2 Ligand-Receptor Pair in Lung Adenocarcinoma: Implications for Prognosis and Therapeutic Strategies	36
Evolutionary dynamics of cancer multidrug resistance in response to olaparib and photodynamic therapy	36
Predicting lymphoma prognosis using machine learning-based genes associated with lactylation	35
Diagnostic assessment of deep learning for melanocytic lesions using whole-slide pathological images	35